You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 936 Post neoadjuvant chemotherapy tissues enriched in a distinct CD27−IgD−CD21-CXCR5- atypical double negative (DN)2 B cells, with potential role in purinergic signalling in early breast cancers

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
936 Post neoadjuvant chemotherapy tissues enriched in a distinct CD27−IgD−CD21-CXCR5- atypical double negative (DN)2 B cells, with potential role in purinergic signalling in early breast cancers

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Carpenter E, Buckley P, Alaguthurai T, et al
936 Post neoadjuvant chemotherapy tissues enriched in a distinct CD27−IgD−CD21-CXCR5- atypical double negative (DN)2 B cells, with potential role in purinergic signalling in early breast cancers
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0936